Lumenari Selected for DoD SBIR Awards
June 14, 2017 08:00 ET
|
Startup Evo, LLC
Lexington, June 14, 2017 (GLOBE NEWSWIRE) -- Lumenari was recently selected for two Phase I awards in the United States Department of Defense (DoD) Small Business Innovative Research (SBIR) Program...
Advanced Space Resource Utilization Technology Projects Supported by New NASA Awards to Deep Space Industries
May 12, 2015 14:19 ET
|
Deep Space Industries Inc.
SILICON VALLEY, Calif., May 12, 2015 (GLOBE NEWSWIRE) -- NASA has selected Deep Space Industries (DSI) for two contracts devoted to developing critical technologies for utilizing asteroid resources....
Xeris Pharmaceuticals Awarded Phase I-II NIH SBIR Fast Track Grant to Advance Stable, Non-Aqueous Glucagon for Treatment of Congenital Hyperinsulinism, an Orphan Disease
April 14, 2015 14:00 ET
|
Xeris Pharmaceuticals, Inc.
Austin, Texas, April 14, 2015 (GLOBE NEWSWIRE) -- Xeris Pharmaceuticals, Inc. (“Xeris”), an Austin-based, emerging biopharmaceutical company developing patient-friendly injectable treatments for...
Xeris Pharmaceuticals Closed 2012 with $6M In Additional Funding
February 11, 2013 09:42 ET
|
Xeris Pharmaceuticals, Inc.
Austin, TX, Feb. 11, 2013 (GLOBE NEWSWIRE) -- Xeris Pharmaceuticals, Inc. ("Xeris"), an Austin-based, emerging
pharmaceutical company developing patient-friendly injectable
treatments for diabetes,...
Xeris Pharmaceuticals Awarded Phase I-II NIH SBIR Fast Track Grant to Advance Stable, Non-Aqueous Glucagon for Bi-Hormonal Artificial Pancreas
July 31, 2012 10:41 ET
|
Xeris Pharmaceuticals, Inc.
Austin, TX, July 31, 2012 (GLOBE NEWSWIRE) -- Xeris Pharmaceuticals, Inc. ("Xeris"), an Austin-based, emerging
biopharmaceutical company developing patient-friendly injectable
treatments for diabetes...
SPIE Applauds Congress for Support of SBIR Reauthorization
December 15, 2011 16:34 ET
|
SPIE
BELLINGHAM, WA--(Marketwire - Dec 15, 2011) - SPIE leaders said they were pleased with the announcement earlier this week by House committee leaders that they had successfully negotiated a deal...
Stellar Biotechnologies Announces Significant Expansion of Keyhole Limpet Hatchery & Sera Production Capability
December 06, 2011 09:18 ET
|
Stellar Biotechnologies, Inc.
PORT HUENEME, CA--(Marketwire - Dec 6, 2011) - Stellar Biotechnologies, Inc. ("Stellar") (TSX VENTURE: KLH) (PINKSHEETS: SBOTF) is pleased to announce the completion of a major expansion of its...
Recent News Stories Highlight Stellar Biotechnologies
November 22, 2011 09:05 ET
|
Stellar Biotechnologies, Inc.
PORT HUENEME, CA--(Marketwire - Nov 22, 2011) - Stellar Biotechnologies, Inc. "Stellar" (TSX-V: KLH) (PINKSHEETS: SBOTF) is pleased to report two recent news stories on the company, by the National...
Stellar Biotechnologies Awarded $498,560 Phase IIB National Science Foundation (NSF) Grant
August 29, 2011 16:05 ET
|
Stellar Biotechnologies, Inc.
PORT HUENEME, CA--(Marketwire - Aug 29, 2011) - Stellar Biotechnologies, Inc. "Stellar" (TSX-V: KLH) (PINKSHEETS: SBOTF) is pleased to announce that the National Science Foundation (NSF) has...
Etegent Technologies Awarded Two Navy Research Contracts
July 21, 2010 12:30 ET
|
Etegent Technologies, Ltd.
CINCINNATI, OH--(Marketwire - July 21, 2010) - Etegent Technologies Ltd., formerly SDL, a high-tech, research and development company, today announced that it has been awarded two Phase I SBIR...